Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV Study.


OBJECTIVE To assess the toxicity and effectiveness of contemporary metastatic castrate-resistant prostate cancer (mCRPC) treatments at a population level, among all patients in Ontario particularly treated with newer agents, including abiraterone, enzalutamide, docetaxel, and cabazitaxel. METHODS We performed a population-based, retrospective cohort study… (More)
DOI: 10.1016/j.urology.2017.08.067


3 Figures and Tables